R&D Systems™ Recombinant Human BDNF Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human BDNF Protein is derived from Sf 21 (baculovirus). The Recombinant Human BDNF Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P23560
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 627
• Molecular Weight (g/mol): 13-14 kDa, under reducing conditions.
• Quantity: 50 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived BDNF protein His129-Arg247 Accession &Num; P23560 100% sequence homology with Mouse,Rat,Canine,Equine and all other mammalian proteins examined.
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: BDNF
• Conjugate: Unconjugated
• Species: Human, Mouse, Rat, Canine, Equine
• Recombinant: Recombinant
• Reconstitution: Reconstitute 5 μg vials at 100 μg/mL in water. Reconstitute 10 μg or larger vials at 250 μg/mL in water.
• Buffer: Lyophilized from a 0.2 μm filtered solution in Sodium Citrate and NaCl with BSA as a carrier protein.
• Purity or Quality Grade: >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.